Global Complement-dependent Cytotoxicity Testing Services Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Complement-dependent Cytotoxicity Testing Services Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Complement-dependent cytotoxicity assay (CDC) is an in vitro cell-based assay used to evaluate the cytotoxic ability of antibodies against target cells. CDC is based on the activation of the complement system and the formation of the membrane attack complex (MAC). In the CDC assay, target cells and antibodies are mixed, and then complement is added. Complement activation leads to the formation of MAC, resulting in the death of target cells. By measuring the survival rate of target cells or the release of molecules that represent cell death, the cytotoxic ability of the antibody can be evaluated. CDC is commonly used in the research and development of antibody drugs, vaccines, and immunotherapies, as well as in the evaluation of the efficacy of these treatments.
Complement-dependent Cytotoxicity Testing Services report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Complement-dependent Cytotoxicity Testing Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Biopharmaceuticals and Medical Diagnosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Complement-dependent Cytotoxicity Testing Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Complement-dependent Cytotoxicity Testing Services key companies include Creative Biolabs, iQ Biosciences, Horizon Discovery, Sino Biological, Inc., GenScript ProBio, Agilent and Sartorius, etc. Creative Biolabs, iQ Biosciences, Horizon Discovery are top 3 players and held % share in total in 2022.
Complement-dependent Cytotoxicity Testing Services can be divided into Common Type and High Throughput Type, etc. Common Type is the mainstream product in the market, accounting for % share globally in 2022.
Complement-dependent Cytotoxicity Testing Services is widely used in various fields, such as Biopharmaceuticals, Medical Diagnosis, Cell Engineering and Medical Treatment, etc. Biopharmaceuticals provides greatest supports to the Complement-dependent Cytotoxicity Testing Services industry development. In 2022, global % share of Complement-dependent Cytotoxicity Testing Services went into Biopharmaceuticals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Complement-dependent Cytotoxicity Testing Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Creative Biolabs
iQ Biosciences
Horizon Discovery
Sino Biological, Inc.
GenScript ProBio
Agilent
Sartorius
Segment by Type
Common Type
High Throughput Type
Biopharmaceuticals
Medical Diagnosis
Cell Engineering
Medical Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Complement-dependent Cytotoxicity Testing Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Complement-dependent Cytotoxicity Testing Services introduction, etc. Complement-dependent Cytotoxicity Testing Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Complement-dependent Cytotoxicity Testing Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Complement-dependent Cytotoxicity Testing Services report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Complement-dependent Cytotoxicity Testing Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Biopharmaceuticals and Medical Diagnosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Complement-dependent Cytotoxicity Testing Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Complement-dependent Cytotoxicity Testing Services key companies include Creative Biolabs, iQ Biosciences, Horizon Discovery, Sino Biological, Inc., GenScript ProBio, Agilent and Sartorius, etc. Creative Biolabs, iQ Biosciences, Horizon Discovery are top 3 players and held % share in total in 2022.
Complement-dependent Cytotoxicity Testing Services can be divided into Common Type and High Throughput Type, etc. Common Type is the mainstream product in the market, accounting for % share globally in 2022.
Complement-dependent Cytotoxicity Testing Services is widely used in various fields, such as Biopharmaceuticals, Medical Diagnosis, Cell Engineering and Medical Treatment, etc. Biopharmaceuticals provides greatest supports to the Complement-dependent Cytotoxicity Testing Services industry development. In 2022, global % share of Complement-dependent Cytotoxicity Testing Services went into Biopharmaceuticals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Complement-dependent Cytotoxicity Testing Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Creative Biolabs
iQ Biosciences
Horizon Discovery
Sino Biological, Inc.
GenScript ProBio
Agilent
Sartorius
Segment by Type
Common Type
High Throughput Type
Segment by Application
Biopharmaceuticals
Medical Diagnosis
Cell Engineering
Medical Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Complement-dependent Cytotoxicity Testing Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Complement-dependent Cytotoxicity Testing Services introduction, etc. Complement-dependent Cytotoxicity Testing Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Complement-dependent Cytotoxicity Testing Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices